Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2019
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Biomarker; Pharmacodynamics; Pharmacokinetics
- Sponsors CONRAD
- 16 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 11 Apr 2014 Planned End Date changed from 1 Apr 2015 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 19 Mar 2013 Planned End Date 1 Apr 2015 added as reported by ClinicalTrials.gov.